§ Dr. LadymanTo ask the Secretary of State for Health what responses he has received from the pharmaceutical industry relating to the publication of the Pharmaceutical Industry Competitiveness Task Force report. [2015]
§ Ms Blears[holding answer 12 July 2001]: The response from the pharmaceutical industry to the publication of the Pharmaceutical Industry Competitiveness Task Force report has been very favourable. The Chairman of Eli Lilly and Company wrote to congratulate my right hon. Friend the Prime Minister on the excellence of the report, informal feedback to Ministers from senior executives of many companies based both here and in the United States of America has been very positive and Japanese companies expressed great interest in the report to the Science Minister, Lord Sainsbury, during his recent visit to Japan. At European Union level, Government and industry are now working together in a similar way on the high level group on Innovation and Provision of Medicines—known as the G10 Group. My noble Friend Lord Hunt of Kings Heath, who co-chaired the United Kingdom task force, is a member of the G10 Group.